Warning: The NCBI web site requires JavaScript to function. more...
Dynamics of different-sized solid-state nanocrystals as tracers for a drug-delivery system in the interstitium of a human tumor xenograft.
Kawai M, Higuchi H, Takeda M, Kobayashi Y, Ohuchi N.
Breast Cancer Res. 2009;11(4):R43. Epub 2009 Jul 3.
Related citations
The effects of particle size and molecular targeting on the intratumoral and subcellular distribution of polymeric nanoparticles.
Lee H, Fonge H, Hoang B, Reilly RM, Allen C.
Mol Pharm. 2010 Aug 2;7(4):1195-208.
Hyperthermia enables tumor-specific nanoparticle delivery: effect of particle size.
Kong G, Braun RD, Dewhirst MW.
Cancer Res. 2000 Aug 15;60(16):4440-5.
Magnetic poly epsilon-caprolactone nanoparticles containing Fe3O4 and gemcitabine enhance anti-tumor effect in pancreatic cancer xenograft mouse model.
Gang J, Park SB, Hyung W, Choi EH, Wen J, Kim HS, Shul YG, Haam S, Song SY.
J Drug Target. 2007 Jul;15(6):445-53.
Final Report on Carcinogens Background Document for Styrene.
National Toxicology Program.
Rep Carcinog Backgr Doc. 2008 Sep;(8-5978):i-398.
Multifunctional nanoparticles for combining ultrasonic tumor imaging and targeted chemotherapy.
Rapoport N, Gao Z, Kennedy A.
J Natl Cancer Inst. 2007 Jul 18;99(14):1095-106. Epub 2007 Jul 10.
In vivo single molecular imaging and sentinel node navigation by nanotechnology for molecular targeting drug-delivery systems and tailor-made medicine.
Takeda M, Tada H, Higuchi H, Kobayashi Y, Kobayashi M, Sakurai Y, Ishida T, Ohuchi N.
Breast Cancer. 2008;15(2):145-52.
Peptide-conjugated biodegradable nanoparticles as a carrier to target paclitaxel to tumor neovasculature.
Yu DH, Lu Q, Xie J, Fang C, Chen HZ.
Biomaterials. 2010 Mar;31(8):2278-92. Epub 2010 Jan 6.
The impact of size on tissue distribution and elimination by single intravenous injection of silica nanoparticles.
Cho M, Cho WS, Choi M, Kim SJ, Han BS, Kim SH, Kim HO, Sheen YY, Jeong J.
Toxicol Lett. 2009 Sep 28;189(3):177-83. Epub 2009 May 3.
Tumor targetability and antitumor effect of docetaxel-loaded hydrophobically modified glycol chitosan nanoparticles.
Hwang HY, Kim IS, Kwon IC, Kim YH.
J Control Release. 2008 May 22;128(1):23-31. Epub 2008 Feb 20.
Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer.
Kukowska-Latallo JF, Candido KA, Cao Z, Nigavekar SS, Majoros IJ, Thomas TP, Balogh LP, Khan MK, Baker JR Jr.
Cancer Res. 2005 Jun 15;65(12):5317-24.
Targeting of alpha(nu)beta(3)-integrins expressed on tumor tissue and neovasculature using fluorescent small molecules and nanoparticles.
Akers WJ, Zhang Z, Berezin M, Ye Y, Agee A, Guo K, Fuhrhop RW, Wickline SA, Lanza GM, Achilefu S.
Nanomedicine (Lond). 2010 Jul;5(5):715-26.
In vivo real-time tracking of single quantum dots conjugated with monoclonal anti-HER2 antibody in tumors of mice.
Tada H, Higuchi H, Wanatabe TM, Ohuchi N.
Cancer Res. 2007 Feb 1;67(3):1138-44.
Systemic delivery of liposomal short-chain ceramide limits solid tumor growth in murine models of breast adenocarcinoma.
Stover TC, Sharma A, Robertson GP, Kester M.
Clin Cancer Res. 2005 May 1;11(9):3465-74.
[VCR-loaded nanoparticles as targeted delivery system for the treatment of orbital adenoid cystic carcinoma].
He YJ, Lin TT, Zhu LM, Luo H, Chang J, Zhang H, Zhang HM.
Zhonghua Yan Ke Za Zhi. 2010 Sep;46(9):795-801. Chinese.
Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy.
Min KH, Park K, Kim YS, Bae SM, Lee S, Jo HG, Park RW, Kim IS, Jeong SY, Kim K, Kwon IC.
J Control Release. 2008 May 8;127(3):208-18. Epub 2008 Feb 7.
A novel cancer targeting approach based on estrone anchored stealth liposome for site-specific breast cancer therapy.
Paliwal SR, Paliwal R, Mishra N, Mehta A, Vyas SP.
Curr Cancer Drug Targets. 2010 May;10(3):343-53.
Final Report on Carcinogens Background Document for Formaldehyde.
Rep Carcinog Backgr Doc. 2010 Jan;(10-5981):i-512.
Three-dimensional MR mapping of angiogenesis with alpha5beta1(alpha nu beta3)-targeted theranostic nanoparticles in the MDA-MB-435 xenograft mouse model.
Schmieder AH, Caruthers SD, Zhang H, Williams TA, Robertson JD, Wickline SA, Lanza GM.
FASEB J. 2008 Dec;22(12):4179-89. Epub 2008 Aug 12.
A polymeric nanoparticle consisting of mPEG-PLA-Toco and PLMA-COONa as a drug carrier: improvements in cellular uptake and biodistribution.
Yi Y, Kim JH, Kang HW, Oh HS, Kim SW, Seo MH.
Pharm Res. 2005 Feb;22(2):200-8.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on